At this time, posts about ST Pharm are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 52,233 shares of ST Pharm, while institutions have bought a net 1,000 shares, according to provisional data. ST Pharm is known as a company specializing in active pharmaceutical ingredients.
As of 11:30 AM on the 19th, ST Pharm's stock price is 73,800 KRW, down 3.91% from the previous day, with a trading volume of 1,075,026 shares, which is 141.38% of the 5-day average trading volume. On November 18, ST Pharm became a market issue with an 18% surge, described as a "contract manufacturing company experiencing a sharp rise."
In addition to ST Pharm, posts by investors are also rapidly increasing for Samsung Engineering (028050), DNA Link (127120), and Sambu Construction (001470).
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
